Mundipharma (United Kingdom)

Recent papers from Mundipharma (United Kingdom)

1. Rezafungin Versus Caspofungin in Candidaemia and Invasive Candidiasis: A Post Hoc Pooled Analysis of Phase 2 and Phase 3 TrialsMycoses · 2026
2. Towards a new model of population mental health research and policy translation in the UK: establishing a National consortium.2026
3. Expert Opinion on Controlled-release Theophylline as an Add-on Therapy in the Management of Chronic Obstructive Pulmonary Disease and AsthmaJournal of Advanced Lung Health · 2026
4. Cost‐Effectiveness of Once Weekly Rezafungin for the Treatment of Invasive Candidiasis in the United KingdomMycoses · 2026
5. Efficacy and Safety of Rezafungin Versus Caspofungin for the Treatment of Candidemia and Invasive Candidiasis in a China Cohort of a Double‐Blind, Randomised, Phase 3 Trial ( ReSTORE China)Mycoses · 2025
6. P12.06.a a Phase 1 Study of Tinostamustine, a Novel Alkylating Deacetylase Inhibitor, as Adjuvant Treatment in Newly Diagnosed MGMT Promoter-Unmethylated GlioblastomaNeuro-Oncology · 2025
7. Rezafungin Versus Caspofungin for the Treatment of Candidemia and Invasive Candidiasis: Results from the Double-blind, Randomized Phase 3 ReSTORE Trial Including the China Extension StudyOpen Forum Infectious Diseases · 2025
8. Iron metabolism dysregulation and ferroptosis: Emerging drivers in pulmonary fibrosis pathogenesis and therapyMolecules and Cells · 2025
9. The rise of mRNA therapeutic vaccinesRSC Pharmaceutics · 2025
10. Safety and Efficacy of Tinostamustine in a Subpopulation of Patients With Relapsed/Refractory Hodgkin Lymphoma From a Phase I TrialHematological Oncology · 2024
11. Clinical and mycological outcomes of candidaemia and/or invasive candidiasis by Candida spp. and antifungal susceptibility: pooled analyses of two randomized trials of rezafungin versus caspofunginClinical Microbiology and Infection · 2024
12. Crucial aspects for maintaining rAAV stabilityScientific Reports · 2024
13. Length of hospital and intensive care unit stay in patients with invasive candidiasis and/or candidemia treated with rezafungin: a pooled analysis of two randomised controlled trialsCritical Care · 2024
14. Rezafungin versus caspofungin for patients with candidaemia or invasive candidiasis in the intensive care unit: pooled analyses of the ReSTORE and STRIVE randomised trialsCritical Care · 2024
15. Bioassay protocol metadata annotation: Proposed standards adoptionSLAS DISCOVERY · 2024
16. Improving HEK293-based AAV-production using GSMMs, and a multi-omics approach2024
17. Using priorities between human and livestock bacterial antimicrobial resistance (AMR) to identify data gaps in livestock AMR surveillanceBMC Infectious Diseases · 2024
18. Synthesis and Characterization of Cobalt-Doped Zno Nanoparticles with Enhanced Photocatalytic ActivityJournal of Educational Research and Policies · 2024
19. Orthogonal characterization of rAAV9 reveals unexpected transgene heterogeneityJournal of Biotechnology · 2024
20. Crucial Aspects for Maintaining rAAV Stability2024